Bengaluru-based Biocon Ltd. is likely to raise $500 million or over ₹4,000 crore by selling shares to institutional investors, sources privy to the matter told CNBC-TV18.
CNBC TV18
4 days ago
Firstpost
Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus
1 day ago
The Economic Times
Syngene Q1 Results: Net profit drops 19% to Rs 76 crore - The Economic Times
6 days ago
CNBC Awaaz
Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday
2 days ago
Biocon - Notification To Stock Exchange
3 days ago
Business Standard India
Biocon Ltd spurts 3.48%, gains for five straight sessions
Biocon Ltd is quoting at Rs 374.45, up 3.48% on the day as on 12:44 IST on the NSE. The stock is up 46.21% in last one year as compared to a 25.73% gain in NIFTY and a 43.88% gain in the Nifty Pharma.
View all
An Indian biopharmaceutical company
biocon.com
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. Wikipedia
Stock price: BIOCON.BO (BSE) ₹359.40 -2.35 (-0.65%)
Tue, Jul 30, 2024, 6:29AM EDT